A 2015 computational study found that predicted disorder in two Ebola nucleocapsid proteins, VP30 and NP, correlated with reported case-fatality rates across Ebola virus types. The authors proposed that disorder could help the virus carry out RNA transcription and bind a wider range of partners. That is a hypothesis, not proof that disorder causes higher lethality or a clinical route to preventing it.
What the 2015 study compared
Gerard Kian-Meng Goh, A. Keith Dunker and Vladimir N. Uversky compared the percentage of predicted intrinsic disorder in Ebola virus proteins VP30 and NP with reported case-fatality rates. Their 2015 paper, “Detection of links between Ebola nucleocapsid and virulence using disorder analysis,” reported a high correlation. PubMed’s record and abstract describe the comparison, but do not provide a numerical correlation coefficient or sample size in the accessible abstract.
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Radio Free Europe | Buy on Amazon |
As an Amazon Associate I earn from qualifying purchases.
Intrinsic disorder means a protein or protein region does not maintain one fixed, well-defined structure across conditions. This does not mean it is biologically inactive: disordered regions can take part in interactions with other molecules. The paper’s central question was whether differences in predicted disorder in VP30 and NP tracked differences in Ebola types’ reported case-fatality rates.
Why the authors thought disorder might matter
VP30 and NP are nucleocapsid proteins, associated with the viral RNA and its functions. The authors suggested that greater disorder could assist viral RNA transcription and allow broader protein binding, potentially supporting viral multiplication and other nucleocapsid functions. These are proposed mechanisms for interpreting the correlation; the abstract does not establish a causal chain from disorder to replication to death.
#1 Best Overall
Uversky later described the correlation as a possible opening for new Ebola vaccine-development strategies in a June 23, 2015 USF Health report. That is a proposed research direction, not evidence that the correlation produced a tested vaccine design or an approved vaccine.
A separate experiment offers molecular context, not causal confirmation
A different study examined a disordered peptide from Ebola VP35, not the cross-strain VP30-and-NP comparison. The peptide, called NPBP and comprising VP35 residues 20–48, was found to bind nucleoprotein (NP). The researchers reported effects on NP oligomerization and the release of RNA from NP–RNA complexes in vitro; they solved the NPBP/NP complex structure at 3.7 Å resolution. See the Cell Reports study, published April 21, 2015.
This experiment shows a specific way a disordered viral peptide can participate in protein interactions under laboratory conditions. It does not test whether disorder differences between Ebola types explain their case-fatality rates, so it cannot validate the earlier study’s strain-level association.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →What the correlation does—and does not—establish
The 2015 analysis reported an association between predicted disorder in two proteins and reported case-fatality rates. Correlation alone cannot show that disorder caused the rate differences. The accessible abstract does not establish the numerical strength of the association, the number of Ebola types included, or a particular threshold for classifying disorder; those details should not be inferred from the phrase “high correlation.”
A separate computational analysis of Ebola sequence changes from 1976 through 2014 found no evidence that amino-acid replacements explained the exceptional scale of the 2014 outbreak. It also found many changes in poorly constrained, intrinsically disordered regions. That study addressed outbreak-scale sequence changes, not the relationship between VP30/NP disorder and case-fatality rates, and should not be treated as confirmation of it. The sequence-analysis paper is available on PubMed Central.
Why the finding remains a hypothesis
The core result is a computational cross-type comparison reported in 2015. It is useful as a possible lead about how protein properties relate to viral biology, but it does not demonstrate a mechanism that increases deaths, explain the severity of a particular outbreak, or establish a treatment or vaccine. The separate VP35 experiment supplies a concrete molecular example of disordered-protein interaction, while answering a different question at a different biological scale.
Chemistry World’s archive lists the title “Intrinsically disordered proteins may be vital in determining the deadliness of Ebola strains” on June 12, 2015. The underlying Molecular BioSystems paper and the related studies cited here appeared in 2015; the evidence presented supports a research hypothesis, not a settled explanation of Ebola lethality.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
